Latest News about NGM
Recent news which mentions NGM
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
February 12, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 03, 2021
From Benzinga
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
January 05, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 30, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
December 29, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 28, 2020
From Benzinga
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
December 22, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 14, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 11, 2020
From Benzinga
The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations
December 10, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 09, 2020
From Benzinga
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 07, 2020
From Benzinga
The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback
November 25, 2020
From Benzinga
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
November 24, 2020
From Benzinga
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
November 13, 2020
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
November 08, 2020
From Benzinga
The Week Ahead In Biotech (Aug. 24-29): Lipocine Binary Event, Liver Congress In The Spotlight
August 23, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For August 3, 2020
August 03, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For July 7, 2020
July 07, 2020
From Benzinga
The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions
June 18, 2020
From Benzinga
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
May 13, 2020
From Benzinga
Analyst Projects Over 130% Upside In This Biopharma
April 07, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For April 7, 2020
April 07, 2020
From Benzinga
From Motley Fool
10 Biggest Price Target Changes For Wednesday
February 26, 2020
From Benzinga
The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
February 25, 2020
From Benzinga
77 Biggest Movers From Yesterday
February 25, 2020
From Benzinga
NGM Biopharmaceuticals Reports a Successful NASH Trial
February 24, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.